Last week the House passed two bipartisan Bills, H.R. 1503 and H.R. 1520, to help lower health costs and prescription drug costs for all Americans by ensuring generic drug companies receive accurate and up to date information on patents for drugs and biological products.
-
Show this thread
Both H.R. 1503 and H.R. 1520 are first steps to putting consumers’ health care first so everyone can afford potentially life-saving prescription drugs.
7:52 AM - 13 May 2019
0 replies
2 retweets
11 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.